The KPNA3 Knockout HT29 Polyclonal Cells represent a CRISPR/Cas9-edited population of HT29 colorectal adenocarcinoma cells with disrupted KPNA3 gene function. KPNA3 encodes karyopherin alpha 3, an adaptor protein that mediates classical NLS-dependent nuclear import. This polyclonal pool avoids clonal selection, providing a heterogeneous knockout model that better reflects the genetic diversity of tumor cell populations for studying nucleocytoplasmic transport in colorectal cancer.
The HT29 cell line is an established epithelial model of human colorectal adenocarcinoma, widely employed in investigations of intestinal epithelial differentiation and colorectal cancer pathogenesis. These adherent cells display epithelial morphology and harbor mutations typical of colorectal tumors, including an activating BRAF mutation and wild-type KRAS. This genetic background renders HT29 particularly suitable for examining signal transduction, drug response, and metastatic mechanisms.
KPNA3 functions as a selective receptor for classical NLS motifs, forming a trimeric import complex with importin beta (KPNB1) and cargo proteins. This complex translocates through nuclear pore complexes via interactions with nucleoporins including Nup62 and Nup153. Nuclear RanGTP binds KPNB1, dissociating the complex and releasing cargo. The Ran GTPase cycle, regulated by factors such as NTF2, ensures directional transport. KPNA3-mediated import is essential for nuclear localization of transcription factors NF-kappaB and STAT3, which regulate genes involved in inflammation, survival, and proliferation. KPNA3 also participates in antiviral responses by mediating nuclear entry of viral components. Key interacting partners include KPNB1, NLS-containing cargo proteins, and nucleoporins.
In colorectal cancer, aberrant nucleocytoplasmic transport redistributes tumor suppressors and oncogenic transcription factors, driving cell cycle dysregulation, proliferation, and metastasis. KPNA3 overexpression, reported in multiple cancers, may enhance nuclear accumulation of NF-kappaB and STAT3, promoting pro-survival signaling and chemoresistance. The HT29 knockout model enables dissection of KPNA3-dependent import pathways within an epithelial colorectal cancer context, facilitating analysis of cargo-specific effects on migration, invasion, and drug sensitivity. Additionally, this system permits investigation of KPNA3??s role in viral replication and host antiviral defenses.
Typical applications encompass western blotting and RT-qPCR for KPNA3 disruption confirmation, immunofluorescence microscopy to visualize mislocalization of NLS cargoes such as NF-kappaB and STAT3, and functional assays including migration, invasion, and drug sensitivity testing. RNA-sequencing can reveal transcriptomic consequences of KPNA3 loss. Researchers may employ these knockout cells to investigate drug resistance mechanisms, define KPNA3-dependent signaling networks, or study host?Cviral interactions in colorectal cancer. This polyclonal knockout population offers a versatile platform for targeted and genome-wide explorations. For further inquiries, please contact Ascent Research.
